Immunogenicity of Comirnaty Omicron XBB.1.5 booster COVID-19 mRNA vaccine in long-term survivors after allogeneic hematopoietic stem cell transplantation

Immunogenicity of Comirnaty Omicron XBB.1.5 booster COVID-19 mRNA vaccine in long-term survivors after allogeneic hematopoietic stem cell transplantation

Abstract Primary mRNA vaccination against COVID-19 typically involves three doses for immunocompromised individuals, including hematopoietic stem cell transplantation (allo-HSCT) recipients. However, optimal subsequent boosting strategies remain unclear. This study aimed to assess the immunogenicity...

Full description

Saved in:
Bibliographic Details
Main Authors: Sigrun Einarsdottir, Samer Al-Dury, Ellen Fridriksson, Linn Dahlsten Andius, Hao Wang, Sinan Sharba, Amin Mountagui, Johan Waern, Johan Ringlander, Anna Martner, Kristoffer Hellstrand, Jesper Waldenström, Martin Lagging
Format: Article
Language:English
Published: Nature Portfolio 2024-10-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-024-74712-x
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-024-74712-x

Similar Items